• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

三叶因子 3 对胃癌患者的诊断和临床病理价值:系统评价和荟萃分析。

The diagnostic and clinicopathological value of trefoil factor 3 in patients with gastric cancer: a systematic review and meta-analysis.

机构信息

Department of Gastroenterology, The First Affiliated Hospital, Jinan University, Guangzhou, P. R. China.

The First Clinical Medical College, Jinan University, Guangzhou, P. R. China.

出版信息

Biomarkers. 2021 Mar;26(2):95-102. doi: 10.1080/1354750X.2020.1871411. Epub 2021 Jan 17.

DOI:10.1080/1354750X.2020.1871411
PMID:33401971
Abstract

OBJECTIVE

To assess the diagnostic value of Trefoil factor 3 (TFF3) and the correlation between TFF3 expression and clinicopathological features in patients with gastric cancer (GC).

METHODS

PubMed, The Cochrane, EMbase, and Web of Science were retrieved comprehensively to collect relevant literature. The search ended on 31 May 2020. All data were analyzed using PubMed, The Cochrane, EMbase, and Web of Science were retrieved to collect relevant articles. All data from the included studies were subjected to meta-analysis using Stata 12.0 software.

RESULTS

Seventeen studies involved 4654 subjects were included. For the diagnostic value of TFF3 for GC, the sensitivity, specificity, and AUC were 0.71, 0.80, and 0.80, respectively. For the clinicopathological value of TFF3, tissue TFF3 expression showed a higher risk of lymph node metastasis (OR 2.20, 95% CI 1.75-2.78,  < 0.001) and muscularis propria invasion (≥T2) (1.51, 1.13-2.03,  = 0.006), as well as worse TNM stage (2.26, 1.63-3.12,  < 0.001) and histological type (1.72, 1.34-2.20,  < 0.001), while no apparent relationship was found for serous membrane invasion (T4), venous invasion, and peritoneal metastasis.

CONCLUSION

TFF3 may be a promising biomarker for GC, and the TFF3 expression is likely to be involved in the invasion, metastasis, and differentiation of GC.

摘要

目的

评估三叶因子 3(TFF3)在胃癌(GC)患者中的诊断价值及其与临床病理特征的相关性。

方法

全面检索 PubMed、The Cochrane、EMbase 和 Web of Science,收集相关文献。检索截止日期为 2020 年 5 月 31 日。使用 Stata 12.0 软件对纳入研究中的所有数据进行荟萃分析。

结果

共纳入 17 项研究,涉及 4654 例患者。对于 TFF3 对 GC 的诊断价值,灵敏度、特异度和 AUC 分别为 0.71、0.80 和 0.80。对于 TFF3 的临床病理价值,组织 TFF3 表达与淋巴结转移(OR 2.20,95%CI 1.75-2.78, < 0.001)和固有肌层侵犯(≥T2)(1.51,1.13-2.03, = 0.006)的风险更高,以及更差的 TNM 分期(2.26,1.63-3.12, < 0.001)和组织学类型(1.72,1.34-2.20, < 0.001),而浆膜侵犯(T4)、静脉侵犯和腹膜转移与 TFF3 表达无明显相关性。

结论

TFF3 可能是 GC 有前途的生物标志物,TFF3 表达可能参与 GC 的侵袭、转移和分化。

相似文献

1
The diagnostic and clinicopathological value of trefoil factor 3 in patients with gastric cancer: a systematic review and meta-analysis.三叶因子 3 对胃癌患者的诊断和临床病理价值:系统评价和荟萃分析。
Biomarkers. 2021 Mar;26(2):95-102. doi: 10.1080/1354750X.2020.1871411. Epub 2021 Jan 17.
2
Reduced expression of TFF1 and increased expression of TFF3 in gastric cancer: correlation with clinicopathological parameters and prognosis.胃癌中 TFF1 表达降低和 TFF3 表达增加:与临床病理参数和预后的相关性。
Int J Med Sci. 2013;10(2):133-40. doi: 10.7150/ijms.5500. Epub 2012 Dec 30.
3
Expression of trefoil factor family members correlates with patient prognosis and neoangiogenesis.三叶因子家族成员的表达与患者预后及新生血管形成相关。
Clin Cancer Res. 2005 Sep 15;11(18):6472-8. doi: 10.1158/1078-0432.CCR-05-0671.
4
Correlation of human epidermal growth factor receptor 2 expression with clinicopathological characteristics and prognosis in gastric cancer.人表皮生长因子受体 2 表达与胃癌临床病理特征及预后的相关性。
World J Gastroenterol. 2013;19(14):2171-8. doi: 10.3748/wjg.v19.i14.2171.
5
Heparanase mRNA and Protein Expression Correlates with Clinicopathologic Features of Gastric Cancer Patients: a Meta- analysis.乙酰肝素酶mRNA和蛋白表达与胃癌患者临床病理特征的相关性:一项Meta分析
Asian Pac J Cancer Prev. 2015;16(18):8653-8. doi: 10.7314/apjcp.2015.16.18.8653.
6
Impact of NPM, TFF3 and TACC1 on the prognosis of patients with primary gastric cancer.核仁磷酸蛋白、三叶因子3和转化酸性卷曲蛋白1对原发性胃癌患者预后的影响。
PLoS One. 2013 Dec 16;8(12):e82136. doi: 10.1371/journal.pone.0082136. eCollection 2013.
7
Prognostic Value of Trefoil Factor 3 Expression in Patients with Gastric Cancer.三叶因子3表达在胃癌患者中的预后价值
World J Surg. 2018 Dec;42(12):3997-4004. doi: 10.1007/s00268-018-4737-0.
8
Phosphorylated Mammalian Target of Rapamycin p-mTOR Is a Favorable Prognostic Factor than mTOR in Gastric Cancer.磷酸化雷帕霉素哺乳动物靶点p-mTOR在胃癌中是比mTOR更有利的预后因素。
PLoS One. 2016 Dec 22;11(12):e0168085. doi: 10.1371/journal.pone.0168085. eCollection 2016.
9
Expression of trefoil factors and TWIST1 in colorectal cancer and their correlation with metastatic potential and prognosis.三叶因子和TWIST1在结直肠癌中的表达及其与转移潜能和预后的相关性。
World J Gastroenterol. 2017 Jan 7;23(1):110-120. doi: 10.3748/wjg.v23.i1.110.
10
TFF3 and survivin expressions associate with a lower survival rate in gastric cancer.TFF3 和 survivin 的表达与胃癌的低生存率相关。
Clin Exp Med. 2013 Nov;13(4):297-303. doi: 10.1007/s10238-012-0210-9. Epub 2012 Sep 21.

引用本文的文献

1
The Past, Present, and Future of Biomarkers for the Early Diagnosis of Pancreatic Cancer.胰腺癌早期诊断生物标志物的过去、现在与未来
Biomedicines. 2024 Dec 13;12(12):2840. doi: 10.3390/biomedicines12122840.
2
Recent Trends and Advancements in the Diagnosis and Management of Gastric Cancer.胃癌诊断与治疗的最新趋势及进展
Cancers (Basel). 2022 Nov 15;14(22):5615. doi: 10.3390/cancers14225615.
3
Diagnostic Value of Spiral CT and Magnetic Resonance Imaging Scanning in Gastric Cancer and Precancerous Lesions.螺旋 CT 和磁共振成像扫描对胃癌及癌前病变的诊断价值。
Scanning. 2022 May 23;2022:3627385. doi: 10.1155/2022/3627385. eCollection 2022.
4
Novel Biomarkers of Gastric Adenocarcinoma: Current Research and Future Perspectives.胃腺癌的新型生物标志物:当前研究与未来展望
Cancers (Basel). 2021 Nov 12;13(22):5660. doi: 10.3390/cancers13225660.
5
Biomarkers in the diagnosis of pancreatic cancer: Are we closer to finding the golden ticket?在胰腺癌诊断中的生物标志物:我们是否更接近找到“金标准”?
World J Gastroenterol. 2021 Jul 14;27(26):4045-4087. doi: 10.3748/wjg.v27.i26.4045.
6
Pretreatment neutrophil-to-lymphocyte ratio predicts the benefit of gastric cancer patients with systemic therapy.治疗前中性粒细胞与淋巴细胞比值可预测接受全身治疗的胃癌患者的获益。
Aging (Albany NY). 2021 Jul 10;13(13):17638-17654. doi: 10.18632/aging.203256.